Stockscreener 앱 받기
3.59
3.16%
0.11
전일 마감가:
$3.48
열려 있는:
$3.52
하루 거래량:
14,341
Relative Volume:
0.02
시가총액:
$437.53M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
100.56
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
-5.53%
1개월 성능:
+15.81%
6개월 성능:
+44.76%
1년 성능:
+12.19%
1일 변동 폭
$3.52
$3.60
1주일 범위
$3.40
$3.85
52주 변동 폭
$2.165
$4.57
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.585 | 437.53M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
173.00 | 77.71B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.595 | 43.05B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.38 | 42.23B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.41 | 19.33B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
151.26 | 15.26B | 2.24B | 385.90M | 440.10M | 3.73 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
A Look At Organogenesis Holdings Inc (ORGO) Stock Performance - Stocks Register
JPMorgan Chase & Co. Increases Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by JPMorgan Chase & Co. - Defense World
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025 - The Manila Times
Organogenesis to Report Q4 and Full Year 2024 Financial Results on February 27 - StockTitan
Organogenesis (ORGO) Stock Price, News & Analysis - MarketBeat
Analysts Issue Forecasts for Organogenesis FY2025 Earnings - Defense World
Analysts Offer Predictions for Organogenesis FY2025 Earnings - MarketBeat
Barclays PLC Acquires 67,855 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Assenagon Asset Management S.A. Has $9.44 Million Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Assenagon Asset Management S.A. Purchases 1,035,120 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Leads These 3 US Penny Stocks - Simply Wall St
Jane Street Group LLC Lowers Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Boosted by Barclays PLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by State Street Corp - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Up 29.1% in December - MarketBeat
Organogenesis signs Smithfield lease with subsidies in hand - The Business Journals
Fmr LLC Buys 44,199 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Commerce Corp. grants tax agreement to Smithfield - Providence Business News
Gary S. Gillheeney Sells 5,585 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) CEO Gary S. Gillheeney Sells 55,615 Shares - MarketBeat
Organogenesis CEO Gary Gillheeney sells shares worth $206,358 - Investing.com
US Penny Stocks To Consider In December 2024 - Simply Wall St
Charles Schwab Investment Management Inc. Grows Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by Verition Fund Management LLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Position Cut by BNP Paribas Financial Markets - Defense World
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 - Investing.com
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 By Investing.com - Investing.com UK
Wound Care Market 2024By Industry Outlook, Future Trends, - openPR
Organogenesis CEO Gillheeney sells shares worth $211,721 - Investing.com India
Organogenesis CEO Gillheeney sells shares worth $211,721 By Investing.com - Investing.com Nigeria
Jacobs Levy Equity Management Inc. Lowers Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc (NASDAQ: ORGO) -0.26% Decline Turns Investors Away - Stocks Register
Organogenesis Holdings Inc. announces an Equity Buyback for 500,000 shares, for $2.03 million. - Marketscreener.com
Organogenesis announces stock repurchase at trailing average price By Investing.com - Investing.com Australia
Organogenesis announces stock repurchase at trailing average price - Investing.com
Advantage Alpha Capital Partners LP Trims Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Mass. firm signs lease for former Rubius facility in Smithfield - Providence Business News
News | Massachusetts-based regenerative tissue medical firm expands in Rhode Island - CoStar Group
News | Massachusetts-based regenerative medical firm expands in Rhode Island - CoStar Group
Organogenesis Expands Manufacturing Capacity to Support Future Growth - The Manila Times
Organogenesis Holdings Inc. Expands Manufacturing Capacity to Support Future Growth - Marketscreener.com
Organogenesis Secures 122,000 Sq Ft Biomanufacturing Facility in Major Expansion | ORGO Stock News - StockTitan
Organogenesis Holdings Inc. Appoints Garrett Lustig to the Board - Marketscreener.com
Analysts Set Expectations for Organogenesis FY2024 Earnings - Defense World
Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock - Global Legal Chronicle
FY2024 EPS Estimates for Organogenesis Boosted by Analyst - MarketBeat
Organogenesis (NASDAQ:ORGO) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Organogenesis Commends Final LCDs - The Manila Times
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.68%
자본화:
|
볼륨(24시간):